Price Alert

Dr. Reddy's Laboratories ... (RDY)

NYSE: RDY · Real-Time Price · USD

14.18

0.07 (0.50%)

At close: Aug 15, 2025, 12:23 PM

Dr. Reddy's Laboratories Income Statement

Financials in INR. Fiscal year is April - March.

Fiscal Year	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Revenue	85.45B	85.06B	83.59B	80.16B	76.73B	70.83B	72.15B	68.8B	67.38B	62.97B	67.7B	63.06B	52.15B	54.37B	53.2B	57.63B	49.19B	47.28B	49.3B	48.97B	44.17B
Cost of Revenue	36.83B	37.8B	34.53B	32.39B	30.38B	29.35B	29.95B	28.43B	27.83B	11.31B	27.61B	25.81B	26.15B	25.63B	24.59B	26.85B	23.5B	21.91B	22.76B	22.56B	19.42B
Gross Profit	48.63B	47.26B	49.05B	47.77B	46.34B	41.48B	42.2B	40.37B	39.55B	51.66B	40.09B	37.25B	26.01B	28.74B	28.61B	30.79B	25.7B	25.38B	26.54B	26.41B	24.75B
Operating Income	17.48B	17.65B	18.72B	17.55B	17.93B	14.79B	17.27B	17.87B	17.64B	21.95B	16.43B	16.13B	12.21B	7.36B	9.23B	12.12B	6.61B	7.57B	2.2B	8.31B	8.11B
Interest Income	1.13B	564M	704M	665M	n/a	647M	583M	719M	329M	474M	273M	216M	217M	1.18B	262M	237M	209M	166M	257M	122M	281M
Pretax Income	19.05B	20.05B	18.74B	19.17B	18.82B	16.02B	18.26B	19.13B	18.46B	13.29B	16.35B	16.11B	14.65B	2.48B	9.71B	12.68B	7.42B	8.07B	2.84B	8.62B	8.79B
Net Income	14.18B	15.94B	14.13B	12.55B	13.92B	13.07B	13.79B	14.8B	14.03B	9.59B	12.47B	11.13B	11.88B	875M	7.07B	9.92B	5.71B	5.54B	198M	7.62B	5.79B
Selling & General & Admin	23.18B	24.05B	24.12B	23.01B	22.69B	20.48B	20.23B	18.8B	17.7B	28.29B	17.98B	16.56B	15.49B	15.67B	15.41B	15.95B	15.04B	14.28B	14.39B	13.11B	12.79B
Research & Development	6.24B	7.26B	6.66B	7.27B	6.19B	6.88B	5.57B	5.45B	4.98B	5.37B	4.82B	4.87B	4.33B	4.33B	4.16B	4.46B	4.53B	4.09B	4.11B	4.36B	3.98B
Other Expenses	1.73B	-1.7B	-443M	-60M	-465M	n/a	n/a	n/a	n/a	-2.39B	800M	-423M	-6B	-291M	-215M	-612M	-458M	-591M	-151M	-163M	-119M
Operating Expenses	31.15B	29.62B	30.33B	30.22B	28.42B	26.49B	25.3B	22.88B	21.91B	31.26B	23.6B	21.01B	13.81B	19.71B	19.36B	19.8B	19.12B	17.79B	18.37B	17.32B	16.65B
Interest Expense	830M	656M	818M	757M	n/a	593M	394M	353M	371M	354M	418M	309M	347M	316M	215M	234M	193M	297M	188M	252M	233M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.53B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	67.98B	67.41B	64.87B	62.61B	58.8B	55.84B	55.24B	51.32B	49.74B	42.58B	51.21B	46.82B	39.96B	45.33B	43.94B	46.65B	42.62B	39.7B	41.13B	39.88B	36.07B
Income Tax Expense	4.95B	4.18B	4.7B	5.75B	4.9B	2.95B	4.47B	4.33B	4.44B	3.69B	3.88B	4.98B	2.78B	1.61B	2.64B	2.76B	1.72B	2.54B	2.65B	998M	3B
Shares Outstanding (Basic)	832.04M	833.31M	833.31M	833.62M	833.93M	832.57M	832.57M	831.83M	830.86M	830.68M	830.4M	825.52M	829.79M	829.79M	829.61M	829.43M	828.69M	829.09M	831.93M	829.31M	828.99M
Shares Outstanding (Diluted)	833.02M	834.3M	834.3M	834.11M	833.93M	833.95M	833.88M	833.52M	832.78M	832.26M	831.81M	831.81M	831.65M	831.75M	831.57M	831.52M	831.1M	831.33M	831.93M	831.66M	830.9M
EPS (Basic)	17.04	19.13	16.96	15.06	16.69	15.70	16.56	17.79	16.88	11.55	15.02	13.48	14.31	1.05	8.52	11.96	6.89	6.68	0.24	9.19	6.99
EPS (Diluted)	17.02	19.10	16.94	15.05	16.69	15.67	16.54	17.76	16.84	11.53	14.99	13.38	14.28	1.05	8.50	11.93	6.87	6.66	0.24	9.17	6.97
EBITDA	24.64B	25.26B	24.28B	23.9B	21.76B	18.5B	21.62B	20.29B	21.22B	16.8B	18.83B	19.37B	9.6B	11.99B	12.28B	13.97B	9.48B	9.63B	11.41B	12.38B	11.25B
EBIT	19.88B	20.71B	19.56B	19.92B	17.91B	16.61B	18.65B	19.49B	17.65B	13.61B	16.76B	16.42B	15B	9.03B	9.92B	12.91B	7.62B	6.46B	3.03B	8.87B	9.02B
Depreciation & Amortization	4.76B	4.55B	4.72B	3.98B	3.81B	3.71B	3.77B	3.79B	3.57B	3.19B	3.27B	3.13B	3.05B	2.96B	2.98B	2.98B	2.9B	3.17B	3.22B	3.27B	3.14B